Antibacterial Agents TRIZ Cases

Modified quinoline derivatives overcome antibiotic resistance by targeting susceptible and resistant bacteria, reducing morbidity.

A recombinant antimicrobial protein derived from Podoviridae bacteriophage targets Staphylococcus aureus cell walls to induce bacterial lysis.

Molecularly dispersed octenidine salts integrate into methacrylate matrices, reducing bacterial adhesion by 80% without compromising material aesthetics.

Internal reservoirs in a PEEK implant use gravity and porosity to sustain antibiotic release, preventing post-surgical infections without external devices.

Azaspiranyl-alkylcarbamate derivatives modify molecular parameters to balance potent FAAH inhibition with improved metabolic stability and safety profiles.

An acidic solvent dissolves the pH-switched chitosan dressing, resolving tissue damage during removal.

Dual enteric-coated dexlansoprazole particles release drug at distinct pH thresholds to maintain therapeutic levels.

Soluble ZcytoR14 receptors neutralize IL-17A and IL-17F simultaneously, resolving the trade-off between treatment specificity and therapeutic comprehensiveness.

Chitosan nanoparticles entrap Clostridium perfringens extracellular proteins to induce mucosal immune responses in poultry.

Modified fluoroquinolone compounds inhibit DNA gyrase, addressing antibiotic resistance in MRSA.

Microwave energy penetrates keratinized tissue to induce superheating and destroy fungal pathogens, avoiding organ toxicity from oral antifungal drugs.

Removing IgG and immunocomplexes from soluble Mycoplasma hyopneumoniae antigens prevents adverse reactions while maintaining protection against swine pathogens.

Targeted peptides inhibit Porphyromonas gingivalis colonization without disrupting beneficial microbiota or promoting antibiotic resistance.

A canine Lyme vaccine uses OspC antigens to induce borreliacidal antibodies that sterilize infected ticks.

Human monoclonal antibodies bind anthrax protective antigen to neutralize toxin activity, resolving inadequate prophylactic protection from current vaccines.

NPAR agonists reverse endothelial dysfunction by blocking arginase upregulation and enhancing nitric oxide synthesis.

Engineered cardiac fibroblast extracellular matrix fragments enable minimally invasive delivery of therapeutic materials to injured tissue.

Low oxygen cultivation of persistently infected McCoy cells reduces bacterial attenuation and eliminates time-consuming re-infection cycles.

Modified Enterococcus faecalis strain eliminates antibiotic-resistant pathogens while preventing horizontal genetic exchange and long-term colonization.

Zinc lysine halide complexes block sweat ducts and kill bacteria without causing irritation from acidic aluminum salts.

Cysteine-free fusion proteins target late-stage antigens to resolve transient epitope coverage limits in chronic TB infections.

Novel nonapeptides WKWLKKWIK, WRKFWKYLK, and RRWRVIVKW deliver strong antimicrobial activity against bacteria, fungi, viruses, and protozoans.

2-Aminopyridine analogs activate glucokinase to improve glycemic control without increasing insulin resistance or hypoglycemia risk.

Engineered soybeans produce stable antigens without purification, resolving manufacturing complexity and enabling ambient storage.

Vacuum-dehydrated Manuka honey microneedles preserve bioactive compounds while delivering targeted bactericidal action against MRSA infections.

Coumestrol-based compositions inhibit matrix metalloproteinase-1 to prevent collagen degradation, addressing environmental damage that accelerates skin aging.

Cyclohexyloxy-substituted heterocycles inhibit tyrosine kinase signal transduction to treat tumoral diseases and respiratory conditions.

A swellable macromolecular coating absorbs antibiotics into a gel matrix to create an antimicrobial surface layer on medical devices.

Water extraction of potato sprouts yields water-soluble peptidoglycan with immunostimulatory activity.

Covalent conjugation of S. aureus serotype 8 capsular polysaccharides to carrier proteins via carbonyl-di-triazole chemistry overcomes poor immunogenicity.

Phosphatidylinositol-specific phospholipase C hydrolyzes non-hydratable phospholipids, enabling migration to the oil-water interface for complete removal.

Structural modifications in aryl sulfonamides enhance bradykinin B1 receptor antagonism for treating neuropathic and inflammatory pain.

A stably tethered bispecific antibody structure uses dimerization and docking domains to form a defined binary complex.

Deuterated gastric H+, K+-ATPase inhibitors replace carbon-hydrogen bonds with deuterium to reduce metabolic oxidation and lower toxicities.

Specific Lactobacillus strains prevent pathogenic biofilms on medical devices, addressing antimicrobial resistance.

Removing sugars via fermentation prevents harmful bacterial growth, enabling effective oral microbial flora balance.

Embedding basic amino acids in bioerodable polymers prevents leaching and erosion, eliminating repeated treatments while maintaining plaque pH.

Selenium nanoparticle core coated with antimicrobial peptides disrupts bacterial membranes, reducing resistance development and cytotoxicity.

A liquid mask film uses garlic extract and sesame oil to form a stable protective layer on nasal mucosa.

A 12-gene biomarker panel detects mortality risk in critically ill patients using transcriptomic profiling.

Crystallization separates toxic phytanic acid from DHA, ensuring safety while maintaining high purity levels.

Replacing rigid imino sugar rings with flexible acyclic chains resolves unpredictability in inhibition potency while maintaining high binding affinity.

Amino acid ester compounds stabilize water-insoluble drugs on medical devices, preventing premature peeling and ensuring rapid release at target tissues.

An engineered microbe detects Pseudomonas aeruginosa presence through protein complex formation and induces antimicrobial peptide production.

Finely dispersed metal particles conceal plastic discoloration without compromising mechanical properties.